0000899243-22-000873.txt : 20220105 0000899243-22-000873.hdr.sgml : 20220105 20220105160603 ACCESSION NUMBER: 0000899243-22-000873 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mamluk Roni CENTRAL INDEX KEY: 0001647053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39279 FILM NUMBER: 22511139 MAIL ADDRESS: STREET 1: CHIASMA, INC. STREET 2: 60WELLS AVENUE CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ayala Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001797336 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823578375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: (857) 444-0553 MAIL ADDRESS: STREET 1: 1313 N. MARKET STREET STREET 2: SUITE 5100 CITY: WILMINGTON STATE: DE ZIP: 19801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-03 0 0001797336 Ayala Pharmaceuticals, Inc. AYLA 0001647053 Mamluk Roni OPPENHEIMER 4 REHOVOT L3 7670104 ISRAEL 1 1 0 0 President & CEO Stock Option 9.105 2022-01-03 4 A 0 127800 0.00 A 2032-01-02 Common Stock 127800 127800 D This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026. /s/ Roni Mamluk, Ph.D. 2022-01-05